Results 151 to 160 of about 839,337 (241)

Correction to: mRNA-1273 SARS-CoV-2 vaccine safety and COVID-19 risk perception in recently transplanted allogeneic hematopoietic stem cell transplant recipients [PDF]

, 2022
Nil Albiol, Olga Aso, Lucía Gómez-Pérez, Mercè Triquell, Nerea Roch, Elisabeth Lázaro, Albert Esquirol, Iria González, Joaquín López‐Contreras, Jorge Sierra, Rodrigo Martino, Irene García‐Cadenas   +11 more
openalex   +1 more source

Single-cell RNA sequencing to decipher the immunogenicity of ChAdOx1 nCoV-19/AZD1222 and mRNA-1273 vaccines in patients with autoimmune rheumatic diseases [PDF]

, 2022
Yen–Ju Chen, Po‐Liang Cheng, Wen‐Nan Huang, Hsin‐Hua Chen, Hongwei Chen, Junpeng Chen, Ching-Tsai Lin, Kuo‐Tung Tang, Wei‐Ting Hung, Tsu‐Yi Hsieh, Yi‐Hsing Chen, Yi‐Ming Chen, Tzu‐Hung Hsiao, Yi-Ming Chen, Yi-Ming Chen, Tzu-Hung Hsiao   +15 more
openalex   +1 more source

Immunogenicity and reactogenicity of intradermal mRNA-1273 SARS-CoV-2 vaccination: a non-inferiority, randomized-controlled trial

npj Vaccines
Fractional dosing can be a cost-effective vaccination strategy to accelerate individual and herd immunity in a pandemic. We assessed the immunogenicity and safety of primary intradermal (ID) vaccination, with a 1/5th dose compared with the standard ...
Manon L M Prins, G. Roozen, C. R. Pothast, Wesley Huisman, R. V. van Binnendijk, G. den Hartog, Vincent P Kuiper, C. Prins, J. Janse, Olivia A. C. Lamers, J. R. Koopman, A. Kruithof, I. Kamerling, R. C. Dijkland, A. D. de Kroon, Shohreh Azimi, M. Feltkamp, M. Kuijer, S. Jochems, M. Heemskerk, F. R. Rosendaal, M. Roestenberg, L. G. Visser, A. Roukens   +23 more
semanticscholar   +1 more source

mrna-1273/tozinameran [PDF]

Reactions Weekly, 2021
  +9 more sources

Demographic and Clinical Factors Associated With SARS-CoV-2 Spike 1 Antibody Response Among Vaccinated US Adults: the C4R Study [PDF]

This study investigates correlates of anti-S1 antibody response following COVID-19 vaccination in a U.S. population-based meta-cohort of adults participating in longstanding NIH-funded cohort studies.
Allen, Norrina B., Anderson, Michaela R., Balte, Pallavi, Bell, Taison D., Bowler, Russell P., Boyle, Rebekah, Cole, Shelley A., Coresh, Josef, Cushman, Mary, Demmer, Ryan T., Doyle, Margaret F., Elkind, Mitchell S. V., Henderson, Joel M., Howard, Virginia J., Isasi, Carmen R., Kanaya, Alka M., Kim, John S., Lee, Joyce S., Make, Barry J., Mantis, Nicholas J., Oelsner, Elizabeth C., Ortega, Victor E., Parker, Monica M., Raffield, Laura M., Regan, Elizabeth A., Schreiner, Pamela J., Schwartz, David A., Styer, Linda M., Sun, Yifei, Tracy, Russell P., Wenzel, Sally E., Woodruff, Prescott, Xanthakis, Vanessa   +32 more
core   +2 more sources

BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the SARS-CoV-2 Delta variant in Qatar

Nature Medicine, 2021
P. Tang, M. Hasan, H. Chemaitelly, H. Yassine, F. Benslimane, H. A. Al Khatib, S. AlMukdad, P. Coyle, H. Ayoub, Z. Al Kanaani, E. Al Kuwari, A. Jeremijenko, A. Kaleeckal, A. Latif, R. M. Shaik, H. A. Abdul Rahim, Gheyath K. Nasrallah, M. A. Al Kuwari, H. A. Al Romaihi, A. Butt, M. H. Al-Thani, A. Al Khal, R. Bertollini, L. Abu-Raddad   +23 more
semanticscholar   +1 more source

Moderna (mRNA Vaccine) for COVID-19: A Leap in Vaccine World

Pharmaceutical and Biomedical Research, 2022
In December 2019, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) appeared and spread worldwide, triggering a pandemic of respiratory illness. So, there was an urgent need for vaccines worldwide.
Anita Rani Bhatia, Arpita Saxena, Nitin Tyagi, Peyir Bagra, Paarth Bhatia   +4 more
doaj  

Zona ophtalmique après vaccination par Pfizer BNT162b2 et Moderna mRNA-1273 chez deux patients jeunes et immunocompétents

, 2022
M A Amblard, E Costantini, George Hayek, X Ricaud   +3 more
openalex   +2 more sources

mRNA-1273 COVID-19 vaccine effectiveness against the B.1.1.7 and B.1.351 variants and severe COVID-19 disease in Qatar

Nature Medicine, 2021
H. Chemaitelly, H. Yassine, F. Benslimane, H. A. Al Khatib, P. Tang, M. Hasan, J. Malek, P. Coyle, H. Ayoub, Z. Al Kanaani, E. Al Kuwari, A. Jeremijenko, A. Kaleeckal, A. Latif, R. M. Shaik, H. A. Abdul Rahim, Gheyath K Nasrallah, M. A. Al Kuwari, H. A. Al Romaihi, M. H. Al-Thani, A. Al Khal, A. Butt, R. Bertollini, L. Abu-Raddad   +23 more
semanticscholar   +1 more source

SARS-CoV-2 vaccination at a High-Complexity Reference Hospital: Implementation and results of an active pharmacovigilance program [PDF]

Programa de Doctorat en Medicina i Recerca Translacional / Tesi realitzada a l'Hospital Clínic[eng] INTRODUCTION: The severe acute respiratory syndrome coronavirus-2 virus (SARS-CoV-2) is the causative agent of the COVID-19 pandemic, which has ...
Sáez Peñataro, Joaquín
core